ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,598Medicare Part D Prescriptions Filled, Including Refills

Rank: 19 out of 434

$776K Total Retail Price of All Prescriptions

Rank: 13 out of 434

774 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
23% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nevada
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 774 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

19% of this provider’s 774 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

1% of this provider’s 11,774 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

17% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $52 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 13.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nevada
LISINOPRIL 688 569 1 1
SIMVASTATIN 661 576 2 2
HYDROCODONE-ACETAMINOPHEN 477 371 S3 3 4
LEVOTHYROXINE SODIUM 445 374 4 3
METFORMIN HCL 435 360 5 7
OMEPRAZOLE 394 311 6 5
ALENDRONATE SODIUM 364 281 7 15
PRAVASTATIN SODIUM 315 221 8 17
METHYLPREDNISOLONE 311 273 9 89
ATENOLOL 288 265 10 16
AMLODIPINE BESYLATE 286 264 11 6
GABAPENTIN 229 193 12 14
LOSARTAN POTASSIUM 222 178 13 13
LOVASTATIN 214 212 14 10
ZOLPIDEM TARTRATE 192 123 15 11
METOPROLOL SUCCINATE 183 141 16 22
RANITIDINE HCL 182 135 17 31
POTASSIUM CHLORIDE 177 148 18 20
METOPROLOL TARTRATE 167 150 19 12
DILTIAZEM 24HR CD 156 126 20 126
FUROSEMIDE 150 125 21 9
CITALOPRAM HBR 143 110 22 23
HYDROCHLOROTHIAZIDE 136 127 23 8
TAMSULOSIN HCL 132 109 24 29
BUMETANIDE 122 81 25 165
TRIAMTERENE-HCTZ 121 74 26 47
AZITHROMYCIN 119 91 27 38
ETODOLAC 119 96 27 137
WARFARIN SODIUM 117 112 29 18
CEPHALEXIN 115 107 30 119
CLOPIDOGREL 109 101 31 41
IBUPROFEN 108 58 32 56
DILTIAZEM 24HR ER 105 93 33 103
GEMFIBROZIL 104 83 34 62
SERTRALINE HCL 103 79 35 27
BENAZEPRIL HCL 96 81 36 49
LANTUS SOLOSTAR 95 71 37 71
CARVEDILOL 84 72 38 24
MORPHINE SULFATE ER 83 53 S2 39 50
GLIMEPIRIDE 82 59 40 58
DIGOXIN 81 81 41 69
ALLOPURINOL 80 71 42 25
DONEPEZIL HCL 78 76 43 35
PROAIR HFA 77 66 44 60
FINASTERIDE 74 73 45 54
TRAMADOL HCL 73 59 46 28
ATORVASTATIN CALCIUM 73 56 46 19
LISINOPRIL-HYDROCHLOROTHIAZIDE 70 64 48 21
FLUTICASONE PROPIONATE 70 49 48 26
FLUOXETINE HCL 69 41 50 32
PLAVIX 68 63 51 64
PEN NEEDLE 68 54 51 83
CIPROFLOXACIN HCL 67 60 53 55
FENOFIBRATE 66 51 54 43
VERAPAMIL ER 65 54 55 78
CLOTRIMAZOLE-BETAMETHASONE 65 54 55 124
TERAZOSIN HCL 64 63 57 40
AVODART 63 56 58 200
PREDNISONE 60 58 59 42
CARISOPRODOL 58 23 R 60 44
RAMIPRIL 57 51 61 136
ACTOS 56 44 62 85
PAROXETINE HCL 55 48 63 61
OXYCODONE HCL-ACETAMINOPHEN 54 40 S2 64 53
INSULIN SYRINGE 52 36 65 120
SPIRIVA 52 48 65 36
LANTUS 52 41 65 80
KLOR-CON 10 50 38 68 116
ONGLYZA 50 39 68 290
CARTIA XT 50 41 68 167
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 20, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.